dehaze (2023) is a pre-seed stage company simplifying personal care by unifying a global health record. Leveraging the data depth, personal diagnoses and treatment decisions can be made to improve patient journeys. Through a fully decentral setup data remains fully with the end users, making the product privacy conform by design.
dehaze is specifically looking for business angels with a focus on health tech and biotech. Prof. Dr. Jan Baumbach, Marius Klages, Dr. Julian Matschinske, Andreas Santoro and Thomas Gläser form the management team of dehaze covering the relevant development and regulatory necessities.